Sarepta Therapeutics Inc: Royal Bank of Canada downgraded industry performance from outperform to sector perform; lowered target price from $157 to $142.
Sarepta Therapeutics Inc：加拿大皇家银行从跑赢大盘下调行业表现；将目标价从157美元下调至142美元
Sarepta Therapeutics Inc: Royal Bank of Canada cuts industry performance from outperforming the market; cuts target price from $157 to $142
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.